RedHill Biopharma (RDHL) Inventory Average (2017 - 2025)

RedHill Biopharma (RDHL) has 9 years of Inventory Average data on file, last reported at $3.4 million in Q2 2025.

• Inventory Average for Q2 2025 came in at $3.4 million, down 16.76% year-over-year; the trailing twelve-month figure through Jun 2025 was $3.4 million (down 16.76% YoY), and the FY2024 annual result was $4.0 million, down 47.79% from the prior year.
• Inventory Average retreated to $3.4 million in Q2 2025 per RDHL's latest filing, from $3.7 million in the prior quarter.
• Over five years, Inventory Average peaked at $13.0 million in Q2 2022 and troughed at $3.4 million in Q2 2025.
• A 5-year average of $8.3 million and a median of $8.7 million in 2021 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2021 and 2023: Inventory Average jumped 239.77% in 2021, then tumbled 60.46% in 2023.
• A 5-year view of Inventory Average shows it stood at $10.4 million in 2021, then climbed by 13.35% to $11.8 million in 2022, then plunged by 60.46% to $4.7 million in 2023, then decreased by 20.08% to $3.7 million in 2024, then decreased by 8.52% to $3.4 million in 2025.
• Business Quant data shows RDHL's Inventory Average at $3.4 million in Q2 2025, $3.7 million in Q4 2024, and $4.1 million in Q2 2024.